U.S.
Haemonetics Up 17%, but the CSL Deal Was Filed in August
Haemonetics rose 17.46% on an 8-K about CSL's rollout, Veradermics gained 14.13% with no stated reason, and Securitize rose 11.05% on reports of tokenized stocks.
1 article(s) on Korean Tokenization stocks, checked against filings and numbers.
Haemonetics rose 17.46% on an 8-K about CSL's rollout, Veradermics gained 14.13% with no stated reason, and Securitize rose 11.05% on reports of tokenized stocks.